Top Key Companies for Antibiotics Active Pharmaceutical Ingredient (API) Market: Sandoz International GmbH, Nanjing Dorra Pharmaceutical Technology Co. Ltd., CordenPharma International, ASIATIC DRUGS & PHARMACEUTICALS PVT. LTD., Aurobindo Pharma Limited, Parabolic Drugs Ltd., Fresenius Kabi, DAEWOONG PHARMACEUTICAL CO. LTD., ACS DOBFAR SPA, Unimark Remedies Ltd., Centrient Pharmaceuticals, Penam Laboratories Ltd., The United Laboratories International Holdings Limited.
Global Antibiotics Active Pharmaceutical Ingredient (API) Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Antibiotics Active Pharmaceutical Ingredient (API) Market Overview And Scope:
The Global Antibiotics Active Pharmaceutical Ingredient (API) Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Antibiotics Active Pharmaceutical Ingredient (API) utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Global Antibiotics Active Pharmaceutical Ingredient (API) Market Segmentation
By Type, Antibiotics Active Pharmaceutical Ingredient (API) market has been segmented into:
Penicillin Antibiotics
Ampicillin
Amoxicillin
Dicloxacillin
Penicillin G Sodium
Benzathine
Procaine
Cephalosporins
Cefotaxime
Ceftriaxone
Cefuroxime
Cefalotin
Carbapenem Antibiotics
Meropenem
Imipenem
Ertapenem
By Application, Antibiotics Active Pharmaceutical Ingredient (API) market has been segmented into:
Pharmaceutical Companies
Contract Manufacturing Organizations (CMOs)
Contract Development & Manufacturing Organizations (CDMOs)
Regional Analysis of Antibiotics Active Pharmaceutical Ingredient (API) Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Antibiotics Active Pharmaceutical Ingredient (API) Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Antibiotics Active Pharmaceutical Ingredient (API) market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Antibiotics Active Pharmaceutical Ingredient (API) market.
Top Key Companies Covered in Antibiotics Active Pharmaceutical Ingredient (API) market are:
Sandoz International GmbH
Nanjing Dorra Pharmaceutical Technology Co. Ltd.
CordenPharma International
ASIATIC DRUGS & PHARMACEUTICALS PVT. LTD.
Aurobindo Pharma Limited
Parabolic Drugs Ltd.
Fresenius Kabi
DAEWOONG PHARMACEUTICAL CO. LTD.
ACS DOBFAR SPA
Unimark Remedies Ltd.
Centrient Pharmaceuticals
Penam Laboratories Ltd.
The United Laboratories International Holdings Limited
Key Questions answered in the Antibiotics Active Pharmaceutical Ingredient (API) Market Report:
1. What is the expected Antibiotics Active Pharmaceutical Ingredient (API) Market size during the forecast period, 2025-2032?
2. Which region is the largest market for the Antibiotics Active Pharmaceutical Ingredient (API) Market?
3. What is the expected future scenario and the revenue generated by different regions and countries in the Antibiotics Active Pharmaceutical Ingredient (API) Market, such as North America, Europe, AsiaPacific & Japan, China, U.K., South America, and Middle East and Africa?
4. What is the competitive strength of the key players in the Antibiotics Active Pharmaceutical Ingredient (API) Market on the basis of the analysis of their recent developments, product offerings, and regional presence?
5. Where do the key Antibiotics Active Pharmaceutical Ingredient (API) companies lie in their competitive benchmarking compared to the factors of market coverage and market potential?
6. How are the adoption scenario, related opportunities, and challenges impacting the Antibiotics Active Pharmaceutical Ingredient (API) Markets?
7. How is the funding and investment landscape in the Antibiotics Active Pharmaceutical Ingredient (API) Market?
8. Which are the leading consortiums and associations in the Antibiotics Active Pharmaceutical Ingredient (API) Market, and what is their role in the market?
Research Methodology for Antibiotics Active Pharmaceutical Ingredient (API) Market Report:
The report presents a detailed assessment of the Antibiotics Active Pharmaceutical Ingredient (API) Market, along with qualitative inputs and insights from Company. This research study involved the extensive use of both primary and secondary sources.Various factors affecting the industry were studied to identify the segmentation types; industry trends; key players; competitive landscape of different products and services provided by separate market players;key market dynamics, such as drivers, restraints, opportunities, challenges, and industry trends; and key player strategies. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights.Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Antibiotics Active Pharmaceutical Ingredient (API) Market by Type
5.1 Antibiotics Active Pharmaceutical Ingredient (API) Market Overview Snapshot and Growth Engine
5.2 Antibiotics Active Pharmaceutical Ingredient (API) Market Overview
5.3 Penicillin Antibiotics
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Penicillin Antibiotics: Geographic Segmentation
5.4 Ampicillin
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Ampicillin: Geographic Segmentation
5.5 Amoxicillin
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Amoxicillin: Geographic Segmentation
5.6 Dicloxacillin
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Dicloxacillin: Geographic Segmentation
5.7 Penicillin G Sodium
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Penicillin G Sodium: Geographic Segmentation
5.8 Benzathine
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Benzathine: Geographic Segmentation
5.9 Procaine
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size (2017-2032F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 Procaine: Geographic Segmentation
5.10 Cephalosporins
5.10.1 Introduction and Market Overview
5.10.2 Historic and Forecasted Market Size (2017-2032F)
5.10.3 Key Market Trends, Growth Factors and Opportunities
5.10.4 Cephalosporins: Geographic Segmentation
5.11 Cefotaxime
5.11.1 Introduction and Market Overview
5.11.2 Historic and Forecasted Market Size (2017-2032F)
5.11.3 Key Market Trends, Growth Factors and Opportunities
5.11.4 Cefotaxime: Geographic Segmentation
5.12 Ceftriaxone
5.12.1 Introduction and Market Overview
5.12.2 Historic and Forecasted Market Size (2017-2032F)
5.12.3 Key Market Trends, Growth Factors and Opportunities
5.12.4 Ceftriaxone: Geographic Segmentation
5.13 Cefuroxime
5.13.1 Introduction and Market Overview
5.13.2 Historic and Forecasted Market Size (2017-2032F)
5.13.3 Key Market Trends, Growth Factors and Opportunities
5.13.4 Cefuroxime: Geographic Segmentation
5.14 Cefalotin
5.14.1 Introduction and Market Overview
5.14.2 Historic and Forecasted Market Size (2017-2032F)
5.14.3 Key Market Trends, Growth Factors and Opportunities
5.14.4 Cefalotin: Geographic Segmentation
5.15 Carbapenem Antibiotics
5.15.1 Introduction and Market Overview
5.15.2 Historic and Forecasted Market Size (2017-2032F)
5.15.3 Key Market Trends, Growth Factors and Opportunities
5.15.4 Carbapenem Antibiotics: Geographic Segmentation
5.16 Meropenem
5.16.1 Introduction and Market Overview
5.16.2 Historic and Forecasted Market Size (2017-2032F)
5.16.3 Key Market Trends, Growth Factors and Opportunities
5.16.4 Meropenem: Geographic Segmentation
5.17 Imipenem
5.17.1 Introduction and Market Overview
5.17.2 Historic and Forecasted Market Size (2017-2032F)
5.17.3 Key Market Trends, Growth Factors and Opportunities
5.17.4 Imipenem: Geographic Segmentation
5.18 Ertapenem
5.18.1 Introduction and Market Overview
5.18.2 Historic and Forecasted Market Size (2017-2032F)
5.18.3 Key Market Trends, Growth Factors and Opportunities
5.18.4 Ertapenem: Geographic Segmentation
Chapter 6: Antibiotics Active Pharmaceutical Ingredient (API) Market by Application
6.1 Antibiotics Active Pharmaceutical Ingredient (API) Market Overview Snapshot and Growth Engine
6.2 Antibiotics Active Pharmaceutical Ingredient (API) Market Overview
6.3 Pharmaceutical Companies
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Pharmaceutical Companies: Geographic Segmentation
6.4 Contract Manufacturing Organizations (CMOs)
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Contract Manufacturing Organizations (CMOs): Geographic Segmentation
6.5 Contract Development & Manufacturing Organizations (CDMOs)
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Contract Development & Manufacturing Organizations (CDMOs): Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Antibiotics Active Pharmaceutical Ingredient (API) Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Antibiotics Active Pharmaceutical Ingredient (API) Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Antibiotics Active Pharmaceutical Ingredient (API) Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 SANDOZ INTERNATIONAL GMBH
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 NANJING DORRA PHARMACEUTICAL TECHNOLOGY CO. LTD.
7.4 CORDENPHARMA INTERNATIONAL
7.5 ASIATIC DRUGS & PHARMACEUTICALS PVT. LTD.
7.6 AUROBINDO PHARMA LIMITED
7.7 PARABOLIC DRUGS LTD.
7.8 FRESENIUS KABI
7.9 DAEWOONG PHARMACEUTICAL CO. LTD.
7.10 ACS DOBFAR SPA
7.11 UNIMARK REMEDIES LTD.
7.12 CENTRIENT PHARMACEUTICALS
7.13 PENAM LABORATORIES LTD.
7.14 THE UNITED LABORATORIES INTERNATIONAL HOLDINGS LIMITED
Chapter 8: Global Antibiotics Active Pharmaceutical Ingredient (API) Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Penicillin Antibiotics
8.2.2 Ampicillin
8.2.3 Amoxicillin
8.2.4 Dicloxacillin
8.2.5 Penicillin G Sodium
8.2.6 Benzathine
8.2.7 Procaine
8.2.8 Cephalosporins
8.2.9 Cefotaxime
8.2.10 Ceftriaxone
8.2.11 Cefuroxime
8.2.12 Cefalotin
8.2.13 Carbapenem Antibiotics
8.2.14 Meropenem
8.2.15 Imipenem
8.2.16 Ertapenem
8.3 Historic and Forecasted Market Size By Application
8.3.1 Pharmaceutical Companies
8.3.2 Contract Manufacturing Organizations (CMOs)
8.3.3 Contract Development & Manufacturing Organizations (CDMOs)
Chapter 9: North America Antibiotics Active Pharmaceutical Ingredient (API) Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Penicillin Antibiotics
9.4.2 Ampicillin
9.4.3 Amoxicillin
9.4.4 Dicloxacillin
9.4.5 Penicillin G Sodium
9.4.6 Benzathine
9.4.7 Procaine
9.4.8 Cephalosporins
9.4.9 Cefotaxime
9.4.10 Ceftriaxone
9.4.11 Cefuroxime
9.4.12 Cefalotin
9.4.13 Carbapenem Antibiotics
9.4.14 Meropenem
9.4.15 Imipenem
9.4.16 Ertapenem
9.5 Historic and Forecasted Market Size By Application
9.5.1 Pharmaceutical Companies
9.5.2 Contract Manufacturing Organizations (CMOs)
9.5.3 Contract Development & Manufacturing Organizations (CDMOs)
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Antibiotics Active Pharmaceutical Ingredient (API) Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Penicillin Antibiotics
10.4.2 Ampicillin
10.4.3 Amoxicillin
10.4.4 Dicloxacillin
10.4.5 Penicillin G Sodium
10.4.6 Benzathine
10.4.7 Procaine
10.4.8 Cephalosporins
10.4.9 Cefotaxime
10.4.10 Ceftriaxone
10.4.11 Cefuroxime
10.4.12 Cefalotin
10.4.13 Carbapenem Antibiotics
10.4.14 Meropenem
10.4.15 Imipenem
10.4.16 Ertapenem
10.5 Historic and Forecasted Market Size By Application
10.5.1 Pharmaceutical Companies
10.5.2 Contract Manufacturing Organizations (CMOs)
10.5.3 Contract Development & Manufacturing Organizations (CDMOs)
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Antibiotics Active Pharmaceutical Ingredient (API) Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Penicillin Antibiotics
11.4.2 Ampicillin
11.4.3 Amoxicillin
11.4.4 Dicloxacillin
11.4.5 Penicillin G Sodium
11.4.6 Benzathine
11.4.7 Procaine
11.4.8 Cephalosporins
11.4.9 Cefotaxime
11.4.10 Ceftriaxone
11.4.11 Cefuroxime
11.4.12 Cefalotin
11.4.13 Carbapenem Antibiotics
11.4.14 Meropenem
11.4.15 Imipenem
11.4.16 Ertapenem
11.5 Historic and Forecasted Market Size By Application
11.5.1 Pharmaceutical Companies
11.5.2 Contract Manufacturing Organizations (CMOs)
11.5.3 Contract Development & Manufacturing Organizations (CDMOs)
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Penicillin Antibiotics
12.4.2 Ampicillin
12.4.3 Amoxicillin
12.4.4 Dicloxacillin
12.4.5 Penicillin G Sodium
12.4.6 Benzathine
12.4.7 Procaine
12.4.8 Cephalosporins
12.4.9 Cefotaxime
12.4.10 Ceftriaxone
12.4.11 Cefuroxime
12.4.12 Cefalotin
12.4.13 Carbapenem Antibiotics
12.4.14 Meropenem
12.4.15 Imipenem
12.4.16 Ertapenem
12.5 Historic and Forecasted Market Size By Application
12.5.1 Pharmaceutical Companies
12.5.2 Contract Manufacturing Organizations (CMOs)
12.5.3 Contract Development & Manufacturing Organizations (CDMOs)
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Penicillin Antibiotics
13.4.2 Ampicillin
13.4.3 Amoxicillin
13.4.4 Dicloxacillin
13.4.5 Penicillin G Sodium
13.4.6 Benzathine
13.4.7 Procaine
13.4.8 Cephalosporins
13.4.9 Cefotaxime
13.4.10 Ceftriaxone
13.4.11 Cefuroxime
13.4.12 Cefalotin
13.4.13 Carbapenem Antibiotics
13.4.14 Meropenem
13.4.15 Imipenem
13.4.16 Ertapenem
13.5 Historic and Forecasted Market Size By Application
13.5.1 Pharmaceutical Companies
13.5.2 Contract Manufacturing Organizations (CMOs)
13.5.3 Contract Development & Manufacturing Organizations (CDMOs)
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Antibiotics Active Pharmaceutical Ingredient (API) Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Penicillin Antibiotics
14.4.2 Ampicillin
14.4.3 Amoxicillin
14.4.4 Dicloxacillin
14.4.5 Penicillin G Sodium
14.4.6 Benzathine
14.4.7 Procaine
14.4.8 Cephalosporins
14.4.9 Cefotaxime
14.4.10 Ceftriaxone
14.4.11 Cefuroxime
14.4.12 Cefalotin
14.4.13 Carbapenem Antibiotics
14.4.14 Meropenem
14.4.15 Imipenem
14.4.16 Ertapenem
14.5 Historic and Forecasted Market Size By Application
14.5.1 Pharmaceutical Companies
14.5.2 Contract Manufacturing Organizations (CMOs)
14.5.3 Contract Development & Manufacturing Organizations (CDMOs)
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Antibiotics Active Pharmaceutical Ingredient (API) Scope:
|
Report Data
|
Antibiotics Active Pharmaceutical Ingredient (API) Market
|
|
Antibiotics Active Pharmaceutical Ingredient (API) Market Size in 2025
|
USD XX million
|
|
Antibiotics Active Pharmaceutical Ingredient (API) CAGR 2025 - 2032
|
XX%
|
|
Antibiotics Active Pharmaceutical Ingredient (API) Base Year
|
2024
|
|
Antibiotics Active Pharmaceutical Ingredient (API) Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Sandoz International GmbH, Nanjing Dorra Pharmaceutical Technology Co. Ltd., CordenPharma International, ASIATIC DRUGS & PHARMACEUTICALS PVT. LTD., Aurobindo Pharma Limited, Parabolic Drugs Ltd., Fresenius Kabi, DAEWOONG PHARMACEUTICAL CO. LTD., ACS DOBFAR SPA, Unimark Remedies Ltd., Centrient Pharmaceuticals, Penam Laboratories Ltd., The United Laboratories International Holdings Limited.
|
|
Key Segments
|
By Type
Penicillin Antibiotics Ampicillin Amoxicillin Dicloxacillin Penicillin G Sodium Benzathine Procaine Cephalosporins Cefotaxime Ceftriaxone Cefuroxime Cefalotin Carbapenem Antibiotics Meropenem Imipenem Ertapenem
By Applications
Pharmaceutical Companies Contract Manufacturing Organizations (CMOs) Contract Development & Manufacturing Organizations (CDMOs)
|